PE20140036A1 - Metodos y composiciones para tratar diarrea asociada con vih - Google Patents

Metodos y composiciones para tratar diarrea asociada con vih

Info

Publication number
PE20140036A1
PE20140036A1 PE2013000926A PE2013000926A PE20140036A1 PE 20140036 A1 PE20140036 A1 PE 20140036A1 PE 2013000926 A PE2013000926 A PE 2013000926A PE 2013000926 A PE2013000926 A PE 2013000926A PE 20140036 A1 PE20140036 A1 PE 20140036A1
Authority
PE
Peru
Prior art keywords
hiv
diarrhea
compositions
methods
treat hiv
Prior art date
Application number
PE2013000926A
Other languages
English (en)
Spanish (es)
Inventor
William Forbes
Enoch Bortey
Steven King
Pravin Chaturvedi
Original Assignee
Napo Pharmaceuticals Inc
Salix Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45994461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20140036(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Napo Pharmaceuticals Inc, Salix Pharmaceuticals Ltd filed Critical Napo Pharmaceuticals Inc
Publication of PE20140036A1 publication Critical patent/PE20140036A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
PE2013000926A 2010-10-31 2011-10-31 Metodos y composiciones para tratar diarrea asociada con vih PE20140036A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40862210P 2010-10-31 2010-10-31
US40933510P 2010-11-02 2010-11-02
US41624910P 2010-11-22 2010-11-22
US201161434379P 2011-01-19 2011-01-19

Publications (1)

Publication Number Publication Date
PE20140036A1 true PE20140036A1 (es) 2014-01-31

Family

ID=45994461

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2013000926A PE20140036A1 (es) 2010-10-31 2011-10-31 Metodos y composiciones para tratar diarrea asociada con vih

Country Status (20)

Country Link
US (4) US8962680B2 (cg-RX-API-DMAC7.html)
EP (1) EP2632550B1 (cg-RX-API-DMAC7.html)
JP (2) JP6063385B2 (cg-RX-API-DMAC7.html)
CN (2) CN107595836A (cg-RX-API-DMAC7.html)
AU (1) AU2011320155B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013010774A2 (cg-RX-API-DMAC7.html)
CA (1) CA2816416C (cg-RX-API-DMAC7.html)
DK (1) DK2632550T3 (cg-RX-API-DMAC7.html)
EC (1) ECSP13012650A (cg-RX-API-DMAC7.html)
ES (1) ES2635435T3 (cg-RX-API-DMAC7.html)
HK (1) HK1249036A1 (cg-RX-API-DMAC7.html)
HU (1) HUE035393T2 (cg-RX-API-DMAC7.html)
MX (1) MX348184B (cg-RX-API-DMAC7.html)
PE (1) PE20140036A1 (cg-RX-API-DMAC7.html)
PH (1) PH12013500857A1 (cg-RX-API-DMAC7.html)
PL (1) PL2632550T3 (cg-RX-API-DMAC7.html)
PT (1) PT2632550T (cg-RX-API-DMAC7.html)
RU (1) RU2597746C2 (cg-RX-API-DMAC7.html)
WO (1) WO2012058664A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201303136B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ595679A (en) 2006-05-01 2013-04-26 Napo Pharmaceuticals Inc Method for treatment of constipation-predominant irritable bowel syndrome
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
CA3025084C (en) 2006-05-01 2021-10-12 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
PL2632550T3 (pl) 2010-10-31 2017-10-31 Napo Pharmaceuticals Inc Sposoby i kompozycja do leczenia biegunki związanej z HIV
EP2928560A4 (en) * 2012-12-07 2016-06-01 Salix Pharmaceuticals Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF HIV-ASSOCIATED DIARRHEA
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
JOP20190276A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
JOP20190275A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج اضطراب إسهال خِلقي
WO2020180424A1 (en) 2019-03-04 2020-09-10 Iocurrents, Inc. Data compression and communication using machine learning
AU2020454132A1 (en) * 2020-06-19 2023-02-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
WO2022115481A1 (en) * 2020-11-24 2022-06-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating post-acute infection gastrointestinal disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
JP4195728B2 (ja) 1996-10-16 2008-12-10 ナポ ファーマシューティカルズ，インコーポレーテッド プロアントシアニジンポリマー止瀉組成物の腸溶製剤
WO2000047062A2 (en) 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
US20040071793A1 (en) 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
WO2005074575A2 (en) 2004-01-30 2005-08-18 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2007002173A1 (en) * 2005-06-22 2007-01-04 University Of Massachusetts Hiv-1 protease inhibitors, and methods of making and using them
CA2633417A1 (en) 2005-12-15 2007-06-21 Bayer Healthcare Ag Diaryl ureas for treating virus infections
CA3025084C (en) 2006-05-01 2021-10-12 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
NZ595679A (en) * 2006-05-01 2013-04-26 Napo Pharmaceuticals Inc Method for treatment of constipation-predominant irritable bowel syndrome
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
US20100092479A1 (en) 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
EA023814B1 (ru) 2009-08-26 2016-07-29 Гленмарк Фармасьютикалс Лтд. Способ получения полимерных композиций на основе проантоцианидина для фармацевтических форм
WO2011044167A1 (en) 2009-10-06 2011-04-14 University Of California, San Francisco Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
US20110087530A1 (en) 2009-10-09 2011-04-14 Visa U.S.A. Inc. Systems and Methods to Provide Loyalty Programs
PL2632550T3 (pl) 2010-10-31 2017-10-31 Napo Pharmaceuticals Inc Sposoby i kompozycja do leczenia biegunki związanej z HIV
BR112013018688B1 (pt) 2011-01-27 2021-08-24 Napo Pharmaceuticals, Inc Método de produção de uma composição polimérica de proantocianidina
MY197454A (en) 2011-12-22 2023-06-19 Napo Pharmaceuticals Inc Non-enteric pharmaceutical composition comprising crofelemer
EP2928560A4 (en) 2012-12-07 2016-06-01 Salix Pharmaceuticals Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF HIV-ASSOCIATED DIARRHEA

Also Published As

Publication number Publication date
US9585868B2 (en) 2017-03-07
JP2017019806A (ja) 2017-01-26
EP2632550B1 (en) 2017-05-03
PH12013500857A1 (en) 2018-01-17
JP6063385B2 (ja) 2017-01-18
RU2597746C2 (ru) 2016-09-20
AU2011320155B2 (en) 2016-02-25
CN107595836A (zh) 2018-01-19
AU2011320155A1 (en) 2013-05-09
HUE035393T2 (en) 2018-05-02
US8962680B2 (en) 2015-02-24
EP2632550A1 (en) 2013-09-04
JP2013540826A (ja) 2013-11-07
PL2632550T3 (pl) 2017-10-31
RU2013123794A (ru) 2014-12-10
DK2632550T3 (en) 2017-08-07
PT2632550T (pt) 2017-08-02
MX2013004873A (es) 2013-08-21
ZA201303136B (en) 2016-01-27
ES2635435T3 (es) 2017-10-03
US20120184605A1 (en) 2012-07-19
US20150190367A1 (en) 2015-07-09
CA2816416C (en) 2020-02-11
CA2816416A1 (en) 2012-05-03
CN103370101A (zh) 2013-10-23
HK1249036A1 (zh) 2018-10-26
JP6310971B2 (ja) 2018-04-11
BR112013010774A2 (pt) 2017-03-21
WO2012058664A1 (en) 2012-05-03
MX348184B (es) 2017-06-02
US20120107370A1 (en) 2012-05-03
EP2632550A4 (en) 2014-04-23
ECSP13012650A (es) 2013-10-31
US20140294903A1 (en) 2014-10-02

Similar Documents

Publication Publication Date Title
PE20140036A1 (es) Metodos y composiciones para tratar diarrea asociada con vih
CL2021001292A1 (es) Terapia de combinación que incluye un inhibidor de krasg12c y uno o más agentes farmacéuticamente activos adicionales para el tratamiento de cánceres
JOP20220008A1 (ar) مثبطات parp1
MX2020005909A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo.
DOP2015000234A (es) COMPOSICIONES DE ARNi CONTRA EL COMPONENTE C5 DEL COMPLEMENTO Y METODOS PARA SU USO.
CO2017001493A2 (es) Kits que comprenden inhibidores tigit y agentes anticáncer
CO6511249A2 (es) Composiciones que comprenden tramadol y celecoxib en el tratamiento del dolor
MX2015016100A (es) Inhibidores de criopirina para prevenir y tratar la inflamacion.
CL2019001996A1 (es) Usos terapéuticos de un polvo de insectos.
MX383254B (es) Combinacion que comprende un glucocorticoide y edo-s101.
MX361602B (es) Síntesis de fibra elástica in vivo.
MX2021013354A (es) Metodos para tratar y/o prevenir queratosis actinica.
MY175764A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof
PE20200794A1 (es) Composicion para su uso en la prevencion y el tratamiento de patologias del aparato cardiovascular
MX2018008078A (es) Tecnologia de sinergismo anticuerpo-farmaco para el tratamiento de enfermedades.
CO2022000270A2 (es) Inhibidores de enzimas
MX2013007735A (es) Fibra y probioticos para reducir sintomas intestinales relacionados con estres cronico.
CL2020000221A1 (es) Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial.
MX2020000694A (es) Composiciones que comprenden darunavir, cobicistat, emtricitabine y alafenamida de tenofovir para usar en el tratamiento del vih.
ZA201906153B (en) Pharmaceutical compositions for combination therapy
BR112017002449A2 (pt) tratamento de sintomas associados com terapia de privação androgênica
MX383214B (es) COMPOSICIONES Y MÉTODOS DE USO DE ß-HIDROXI-ß-METILBUTIRATO (HMB) PARA AUMENTAR LA RECUPERACIÓN DE TRAUMA DE TEJIDO BLANDO.
EA201991866A1 (ru) Комбинированная терапия
MY174065A (en) Methods and compositions for treating hiv-associated diarrhea
UA109763C2 (ru) Способ лечения паховых и пахово-мошоночных грыж у новорожденных и мальчиков младшей возрастной группы

Legal Events

Date Code Title Description
FC Refusal